SCHEMBL16619844

SCHEMBL16619844

CC(C(=O)O)n1ccc2cc(Br)ccc21

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NTSR1 P30989 1/20 0.50
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
MCL1 Q07820 1/20 0.45
FABP4 P15090 2/20 0.42
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 1/20 0.41
FABP3 P05413 1/20 0.40
FABP2 P12104 1/20 0.40
FABP5 Q01469 1/20 0.40
FPR2 P25090 1/20 0.39
PTGS2 P35354 1/20 0.37
OXER1 Q8TDS5 1/20 0.36
PPARA Q07869 2/20 0.35
HTT P42858 1/20 0.35
KRAS P01116 2/20 0.35
ROCK1 Q13464 1/20 0.35
HTR7 P34969 1/20 0.35
HSP90AA1 P07900 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22798848 1.00 NTSR1 (0.50) NTSR1HTR2AHTR2CMCL1FABP4
SCHEMBL16627458 1.00 NTSR1 (0.50) NTSR1HTR2AHTR2CMCL1FABP4
SCHEMBL2012022 0.86 HTR2A (0.49) NTSR1HTR2AHTR2CMCL1FABP4
SCHEMBL16627490 0.84 NTSR1 (0.44) NTSR1HTR2AHTR2CMCL1FABP4
SCHEMBL16627486 0.84 NTSR1 (0.44) NTSR1HTR2AHTR2CMCL1FABP4
SCHEMBL6258605 0.83 HTR2A (0.45) HTR2AHTR2CFABP4SLC6A2SLC6A4
SCHEMBL2002647 0.83 PTGS2 (0.38) NTSR1PTGS2
SCHEMBL16627489 0.81 FPR2 (0.45) NTSR1HTR2AHTR2CMCL1SLC6A2
SCHEMBL22798770 0.81 SLC6A2 (0.48) HTR2AHTR2CSLC6A2SLC6A4PTGS2
SCHEMBL22798768 0.81 SLC6A2 (0.48) HTR2AHTR2CSLC6A2SLC6A4PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3753560-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2020-12-23 EP claimed
EP-3753560-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2020-12-23 EP disclosed
WO-2015049668-A1 NOVEL COMPOUND AS A DIACYLGLYCEROL ACYLTRANSFERASE INHIBITOR GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2015-04-09 WO disclosed